| |
 |
|
Class Information
Number: 514/236.2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.) > Three or more ring hetero atoms in the additional hetero ring
Description: Subject matter in which the additional hetero ring contains at least three ring hetero atoms.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7598245 |
Aminotriazole compounds useful as inhibitors of protein kinases |
Oct. 6, 2009 |
| 7592337 |
Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
Sep. 22, 2009 |
| 7572782 |
Use of targeted oxidative therapeutic formulation in bone regeneration |
Aug. 11, 2009 |
| 7560483 |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
Jul. 14, 2009 |
| 7507726 |
Peptide deformylase inhibitors |
Mar. 24, 2009 |
| 7425555 |
Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
Sep. 16, 2008 |
| 7410967 |
Pyridodiazines as plant fungicides |
Aug. 12, 2008 |
| 7393869 |
Methods of using thiazolidine derivatives to treat cancer or inflammation |
Jul. 1, 2008 |
| 7378423 |
Pyrimidine compound and medical use thereof |
May. 27, 2008 |
| 7304062 |
Peroxisome proliferator activated receptor alpha agonists |
Dec. 4, 2007 |
| 7232820 |
Thiadiazole-amine compounds for the treatment of neurodegenerative disorders |
Jun. 19, 2007 |
| 7226921 |
Compounds and compositions as cathepsin S inhibitors |
Jun. 5, 2007 |
| 7226920 |
Aminotriazole compounds useful as inhibitors of protein kinases |
Jun. 5, 2007 |
| 7220745 |
Heterocyclic compounds useful to treat HCV |
May. 22, 2007 |
| 7217714 |
CCR5 modulators |
May. 15, 2007 |
| 7173030 |
Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 |
Feb. 6, 2007 |
| 7169768 |
Method of decreasing atherosclerosis and its complications |
Jan. 30, 2007 |
| 7091203 |
Imidazo[1,3,5]triazinones and their use |
Aug. 15, 2006 |
| 7091196 |
Bifunctional heterocyclic compounds and methods of making and using same |
Aug. 15, 2006 |
| 7084139 |
Pyrrolidin-2-one derivatives as inhibitors of factor Xa |
Aug. 1, 2006 |
| 7074788 |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
Jul. 11, 2006 |
| 7064123 |
Compounds and compositions as cathepsin inhibitors |
Jun. 20, 2006 |
| 7045520 |
Opioid receptor active compounds |
May. 16, 2006 |
| 7030149 |
Combination of brimonidine timolol for topical ophthalmic use |
Apr. 18, 2006 |
| 7022705 |
Isoxazoline derivatives useful as antimicrobials |
Apr. 4, 2006 |
| 7022702 |
Antiproliferative 1,2,3-thiadiazole compounds |
Apr. 4, 2006 |
| 6977256 |
Compounds and compositions as cathepsin S inhibitors |
Dec. 20, 2005 |
| 6956037 |
Benzamide derivatives for the treatment of diseases mediated by cytokines |
Oct. 18, 2005 |
| 6949518 |
Methods for treating macular degeneration with topiramate |
Sep. 27, 2005 |
| 6900207 |
N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient |
May. 31, 2005 |
| 6894046 |
IL-5 inhibiting 6-azauracil derivatives |
May. 17, 2005 |
| 6884797 |
Targeted oxidative therapeutic formulation |
Apr. 26, 2005 |
| 6858609 |
Substituted diamino-1,3,5-triazine derivatives |
Feb. 22, 2005 |
| 6852719 |
Glucocorticoid receptor modulators |
Feb. 8, 2005 |
| 6841551 |
Brain, spinal, and nerve injury treatment |
Jan. 11, 2005 |
| 6821972 |
3-heterocyclylpropanohydroxamic acid PCP inhibitors |
Nov. 23, 2004 |
| 6803365 |
Imidazo[1,3,5]triazinones and the use thereof |
Oct. 12, 2004 |
| 6730671 |
Compounds useful as reversible inhibitors of cathespin S |
May. 4, 2004 |
| 6723742 |
Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Apr. 20, 2004 |
| 6686388 |
Regulators of the hedgehog pathway, compositions and uses related thereto |
Feb. 3, 2004 |
| 6649614 |
Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent for treatment of depression or anxiety |
Nov. 18, 2003 |
| 6642234 |
Acrylonitrile compounds |
Nov. 4, 2003 |
| 6638930 |
Morpholine and thiomorpholine tachykinin receptor antagonists |
Oct. 28, 2003 |
| 6630468 |
Disubstituted pyrazolines and triazolines as factor Xa inhibitors |
Oct. 7, 2003 |
| 6624165 |
Cyclopentene derivatives useful as antagonists of the motilin receptor |
Sep. 23, 2003 |
| 6613765 |
Use of NK-1 receptor antagonists for treating major depressive disorders |
Sep. 2, 2003 |
| 6610677 |
Pyrazole compounds useful as protein kinase inhibitors |
Aug. 26, 2003 |
| 6608057 |
Compounds useful as reversible inhibitors of cathepsin S |
Aug. 19, 2003 |
| 6605623 |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
Aug. 12, 2003 |
| 6596750 |
Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Jul. 22, 2003 |
|
|
|
